NLM Digital Collections


Search Constraints

Start Over You searched for: Subjects Investigational New Drug Application Remove constraint Subjects: Investigational New Drug Application

Search Results

2. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

3. Systemic antibacterial and antifungal drugs: susceptibility test interpretive criteria labeling for NDAs and ANDAs

4. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system

5. Best practices for communication between IND sponsors and FDA during drug development: guidance for industry and review staff : good review practice

6. Form FDA 3674--certifications to accompany drug, biological product, and device applications/submissions: guidance for sponsors, industry, researchers, investigators, and food and drug administration staff

8. Generic Drug User Fee Amendments of 2012: questions and answers related to self-identification of facilities, review of generic drug submissions, and inspections and compliance

9. Antibacterial therapies for patients with an unmet medical need for the treatment of serious bacterial diseases

10. Antibiotics: FDA has encouraged development, but needs to clarify the role of draft guidance and develop qualified infectious disease product guidance : report to Congressional requesters